Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JTECTSE:3446 -0.21%56 Gross Margin % is 62.76% as of Mar. 2026, which is 1% above its 10-year median of 62.17. GuruFocus rates TSE:3446 with a GF Score™ of 56/100 and a GF Value™ of 円2,140.06 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 805 Medical Devices & Instruments companies, JTEC ranks better than 66.21% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. JTEC's Gross Profit for the
three
months ended in Mar. 2026 was 円248 Mil. JTEC's Revenue for the
three
months ended in Mar. 2026 was 円394 Mil. Therefore, JTEC's Gross Margin % for the quarter that ended in Mar. 2026 was 62.76%.
The historical rank and industry rank for JTEC's Gross Margin % or its related term are showing as below:
TSE:3446'
s Gross Margin % Range Over the Past 10 Years
Min: 60.81 Med: 62.17 Max: 79.02
Current: 62.37
During the past 9 years, the highestGross Margin % of JTEC was 79.02%. The lowest was 60.81%. And the median was 62.17%.
TSE:3446's Gross Margin % is ranked better than 66.21% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.07
vs TSE:3446: 62.37
JTEC had a gross margin of 62.76% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for JTEC was 0.00% per year.
JTEC (TSE:3446) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
JTEC had a gross margin of 62.76% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
JTEC Gross Margin % Related Terms
JTEC Gross Margin % Historical Data
* Premium members only.
The historical data trend for JTEC's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:3446 vs ISRG, BDX, MDLN: Gross Margin % Comparison
For the Medical Instruments & Supplies subindustry, JTEC's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JTEC Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, JTEC's Gross Margin % distribution charts can be found below:
* The bar in red indicates where JTEC's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
JTEC (TSE:3446) has a Gross Margin % of 62.76% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on JTEC and its competitors. This is near median its historical median of 62.17. Over the past decade, JTEC's Gross Margin % has ranged from 60.81 to 79.02. According to the industry distribution chart, JTEC ranks #272 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 33.8%.
Is JTEC's Gross Margin % too high?
JTEC's current Gross Margin % of 62.76% is near median its 10-year median of 62.17. Over the past 10 years, this metric has ranged from a low of 60.81 to a high of 79.02. The Medical Devices & Instruments industry median Gross Margin % is 52.07. JTEC's value of 62.76% is 20.5% above this industry median. Based on the distribution chart, JTEC ranks #272 out of 805 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, JTEC has a GF Score™ of 56/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JTEC's Gross Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, JTEC ranks #272 out of 805 companies for Gross Margin %. This puts JTEC in the upper half of its industry. The industry median Gross Margin % is 52.07. JTEC's value of 62.76% is 20.5% above this benchmark. Historically, JTEC's own Gross Margin % has ranged from 60.81 to 79.02 over the past decade. While the company's 10-year median is 62.17 vs. the industry median of 52.07, JTEC has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JTEC's current Gross Margin % of 62.76% is 20.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on JTEC and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JTEC's current Gross Margin % is 62.76%, which is near median its own 10-year median of 62.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JTEC stock overvalued right now?
Based on GuruFocus' analysis, JTEC (TSE:3446) is currently considered Significantly Undervalued. The stock's GF Value™ is 円2,140.06, compared to a current price of 円1,440.00 — trading 32.7% below its estimated fair value. The current Gross Margin % is 62.76%, which is near median its 10-year median of 62.17 and 20.5% above the Medical Devices & Instruments industry median of 52.07. JTEC's overall GF Score™ is 56/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For JTEC (TSE:3446), the current Gross Margin % is 62.76% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JTEC (TSE:3446) Overvalued in 2026?
Based on GuruFocus' analysis, JTEC stock appears to be undervalued.
The current stock price of 円1,440.00 is trading 32.7% below its estimated GF Value™ of 円2,140.06.
GuruFocus considers JTEC to be Significantly Undervalued.
Key valuation signals for TSE:3446:
Gross Margin %: 62.76% (near median its 10-year median of 62.17)
GF Value™: 円2,140.06 vs. price of 円1,440.00 (32.7% below fair value)
Industry Position: 20.5% above the Medical Devices & Instruments median (#272 of 805)
No single metric tells the full story. See the TSE:3446 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JTEC Corp is engaged in developing, designing, manufacturing and sales of Automated Cell Culture System; X-ray Mirrors for Synchrotron Facilities; and Automated System in various fields. Its products in optical business include Kirkpatrick-Baez (KB) mirror, Advanced KB mirror (1D Wolter mirror), Montel mirror, Ellipsoidal mirror, 2D Walter mirror, Deformable mirror, Multi-channel mirror, X-ray focusing alignment system (JM1000 / 2000 series), Additional mirror shaping improvement, and Mirror coating. Its products in life science include CELLFLOAT products and Automated Cell Culture Systems.
56GF Score
Get the complete analysis for TSE:3446
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3446 has been successfully added to your 
